High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating Disease
The exact cause of multiple sclerosis (MS) is unknown; however, it is considered to be an inflammatory disease of the central nervous system (CNS) triggered by a combination of both environmental and genetic factors. Vitamin D deficiency is also discussed as a possible disease-promoting factor in MS...
Main Authors: | Darius Häusler, Sebastian Torke, Martin S. Weber |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2020-02-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | https://www.frontiersin.org/article/10.3389/fimmu.2020.00301/full |
Similar Items
-
Hypercalcemia and Neurological Symptoms: A Rare Presentation of Hyperfunctioning Parathyroid Adenoma in an Adolescent
by: Valeria Calcaterra, et al.
Published: (2022-05-01) -
Aquaporin-4 Immuneglobulin G testing in 36 consecutive Jamaican patients with inflammatory central nervous system demyelinating disease
by: Sherri Sandy, et al.
Published: (2014-08-01) -
Editorial: Pediatric multiple sclerosis - from bench to bedside
by: Ethel Ciampi, et al.
Published: (2024-04-01) -
A Comprehensive Review on Neuroimmunology: Insights from Multiple Sclerosis to Future Therapeutic Developments
by: Lucian Eva, et al.
Published: (2023-09-01) -
Perspectives on cytokine-directed therapies in multiple sclerosis
by: Bettina Schreiner, et al.
Published: (2015-10-01)